GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » PB Ratio

TELO (Telomir Pharmaceuticals) PB Ratio : 124.55 (As of Apr. 01, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-01), Telomir Pharmaceuticals's share price is $2.74. Telomir Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was $0.02. Hence, Telomir Pharmaceuticals's PB Ratio of today is 124.55.

The historical rank and industry rank for Telomir Pharmaceuticals's PB Ratio or its related term are showing as below:

TELO' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 187.66
Current: 137

During the past 4 years, Telomir Pharmaceuticals's highest PB Ratio was 187.66. The lowest was 0.00. And the median was 0.00.

TELO's PB Ratio is ranked worse than
99.69% of 1274 companies
in the Biotechnology industry
Industry Median: 2.29 vs TELO: 137.00

During the past 12 months, Telomir Pharmaceuticals's average Book Value Per Share Growth Rate was -81.00% per year.

Back to Basics: PB Ratio


Telomir Pharmaceuticals PB Ratio Historical Data

The historical data trend for Telomir Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals PB Ratio Chart

Telomir Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23 Dec24
PB Ratio
- - - 187.27

Telomir Pharmaceuticals Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 50.49 90.75 428.00 187.27

Competitive Comparison of Telomir Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, Telomir Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telomir Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telomir Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Telomir Pharmaceuticals's PB Ratio falls into.


;
;

Telomir Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Telomir Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=2.74/0.022
=124.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Telomir Pharmaceuticals  (NAS:TELO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Telomir Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Telomir Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Telomir Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
100 South East, 2nd Street, Suite 200, No.1009, Miami, FL, USA, 33131
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Telomir Pharmaceuticals Headlines

From GuruFocus